Article (Peer-reviewed): Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations by T. Andrasfay and N. Goldman (Proceedings of the National Academy of Sciences, February 2021), available at https://www.pnas.org/content/118/5/e2014746118 (NOTE: This article provides evidence that Black and Latinx populations have been negatively impacted by the COVID pandemic. It can serve as a helpful source to cite in scientific articles and grant proposals, as well as administrative planning documents.)
Article (governmental): Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years — 16 U.S. Jurisdictions, January 1–December 31, 2020 (Morbidity & Mortality Weekly Report [MMWR], Centers for Disease Control and Prevention, 2021), available at https://www.cdc.gov/mmwr/volumes/70/wr/mm7011e1.htm?s_cid=mm7011e1_w . (NOTE: This research study contains analysis of one year’s worth of data on the COVID-19 epidemic in the U.S..)
Public Health (including Epidemiology and Health Policy)
Webinars (with Live Updates): Responding to COVID-19: A Science-Based Approach (American Public Health Association, 2020), available at https://covid19conversations.org
Article (Peer-reviewed/governmental): Estimated Resource Costs for Implementation of CDC’s Recommended COVID-19 Mitigation Strategies in Pre-Kindergarten through Grade 12 Public Schools — United States, 2020–21 School Year by K. Rice, G. Miller, F. Coronado, and M. Meltzer (CDC MMWR, 2020), available at https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e1.htm?s_cid=mm6950e1_w(NOTE: This article published by the U.S. government’s CDC may be of particular interest to administrators working with K-12 schools as well as educators in education, public health, business, health services administration, school administration, as well as other health-related studies.)
Article (Peer-reviewed): An evidence review of face masks against COVID-19 by J. Howard, A. Huang, Z. Li, et al. (Proceedings of the National Academy of Sciences, January 2021), available at https://www.pnas.org/content/118/4/e2014564118(NOTE: This article reviews the latest evidence-based studies on the effectiveness of face masks in preventing infection with SARS-CoV-2, the virus that causes COVID-19 disease. It may be very helpful to faculty, staff, and administrators. )
Article (Peer-reviewed/research letter): National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020 by P.G. Szilagyi, K. Thomas, M.D. Shah, et al. (JAMA, December 2020), available at https://jamanetwork.com/journals/jama/fullarticle/2774711
SPECIAL REPORT: 2020 Year-End COVID Update from Columbia University’s ICAP, based at the Mailman School of Public Health; you may download the report here .
Article (governmental): Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 (Morbidity & Mortality Weekly Report [MMWR], Centers for Disease Control and Prevention, 2021), available at https://www.cdc.gov/mmwr/volumes/70/wr/mm7007e1.htm .
Website: The COVID Tracking Project at The Atlantic (The Atlantic Monthly Group, 2020) available at https://covidtracking.com(NOTE: Per the authors of the site, “[t]he COVID Tracking Project collects and publishes the most complete data about COVID-19 in the US.” The website shut down on 3-7-21 but the data are still available for viewing.)
Article (peer-reviewed): Impact of the influenza vaccine on COVID-19 infection rates and severity by A. Conlon, C. Ashur, L. Washer, K. Eagle, and M. Hofmann-Bowman (American Journal of Infection Control, February 2021), available at https://www.ajicjournal.org/article/S0196-6553(21)00089-4/fulltext . (NOTE: This is a research study on the correlations between receiving the flu vaccine and COVID infections.)
Article (governmental): Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 (Morbidity & Mortality Weekly Report [MMWR], Centers for Disease Control and Prevention, 2021), available at https://www.cdc.gov/mmwr/volumes/70/wr/mm7018e1.htm?s_cid=mm7018e1_w .
Article (governmental): First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 (Morbidity & Mortality Weekly Report [MMWR], Centers for Disease Control and Prevention, 2021), available at https://www.cdc.gov/mmwr/volumes/70/wr/mm7008e3.htm?s_cid=mm7008e3_w (NOTE: This MMWR article discusses very reassuring results from the first month of safety data for the Pfizer BioNTech and Moderna COVID-19 vaccines administered in the U.S.)
Article (governmental): Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 (Morbidity & Mortality Weekly Report [MMWR], Centers for Disease Control and Prevention, 2021), available at https://www.cdc.gov/mmwr/volumes/70/wr/mm7017e4.htm?s_cid=mm7017e4_w .